BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17339454)

  • 21. Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide.
    Kim JY; Bae JH; Lee SH; Lee EY; Chung BS; Kim SH; Kang CD
    J Immunother; 2008 Jun; 31(5):475-86. PubMed ID: 18463537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation.
    Gadue P; Stein PL
    J Immunol; 2002 Sep; 169(5):2397-406. PubMed ID: 12193707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
    Gilfillan S; Ho EL; Cella M; Yokoyama WM; Colonna M
    Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival.
    Felices M; Berg LJ
    J Immunol; 2008 Mar; 180(5):3007-18. PubMed ID: 18292523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells.
    Lanier LL; Corliss BC; Wu J; Leong C; Phillips JH
    Nature; 1998 Feb; 391(6668):703-7. PubMed ID: 9490415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Porcine UL16-binding protein 1 expressed on the surface of endothelial cells triggers human NK cytotoxicity through NKG2D.
    Lilienfeld BG; Garcia-Borges C; Crew MD; Seebach JD
    J Immunol; 2006 Aug; 177(4):2146-52. PubMed ID: 16887974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines.
    Okita R; Mougiakakos D; Ando T; Mao Y; Sarhan D; Wennerberg E; Seliger B; Lundqvist A; Mimura K; Kiessling R
    J Immunol; 2012 Mar; 188(5):2136-45. PubMed ID: 22301547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self-antigen presenting cells and stromal cells.
    Poggi A; Prevosto C; Zancolli M; Canevali P; Musso A; Zocchi MR
    Ann N Y Acad Sci; 2007 Aug; 1109():47-57. PubMed ID: 17785290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands.
    Elsner L; Muppala V; Gehrmann M; Lozano J; Malzahn D; Bickeböller H; Brunner E; Zientkowska M; Herrmann T; Walter L; Alves F; Multhoff G; Dressel R
    J Immunol; 2007 Oct; 179(8):5523-33. PubMed ID: 17911639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12.
    Parihar R; Trotta R; Roda JM; Ferketich AK; Tridandapani S; Caligiuri MA; Carson WE
    Cancer Res; 2005 Oct; 65(19):9099-107. PubMed ID: 16204085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunoediting of natural killer cells by human nasopharyngeal carcinoma cell line: altered expression of KIRs and NKG2D receptors leads to reduction of natural killer cell-mediated cytolysis].
    Guo KY; Mei JZ; Yao KT
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):247-9. PubMed ID: 17425963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment.
    Rabot M; El Costa H; Polgar B; Marie-Cardine A; Aguerre-Girr M; Barakonyi A; Valitutti S; Bensussan A; Le Bouteiller P
    Int Immunol; 2007 Apr; 19(4):401-9. PubMed ID: 17307798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.
    Rölle A; Mousavi-Jazi M; Eriksson M; Odeberg J; Söderberg-Nauclér C; Cosman D; Kärre K; Cerboni C
    J Immunol; 2003 Jul; 171(2):902-8. PubMed ID: 12847260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
    Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
    Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis.
    Eischen CM; Schilling JD; Lynch DH; Krammer PH; Leibson PJ
    J Immunol; 1996 Apr; 156(8):2693-9. PubMed ID: 8609385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A key role for Itk in both IFN gamma and IL-4 production by NKT cells.
    Au-Yeung BB; Fowell DJ
    J Immunol; 2007 Jul; 179(1):111-9. PubMed ID: 17579028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway.
    Westwood JA; Kelly JM; Tanner JE; Kershaw MH; Smyth MJ; Hayakawa Y
    J Immunol; 2004 Jan; 172(2):757-61. PubMed ID: 14707044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
    Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
    J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells.
    El-Sherbiny YM; Meade JL; Holmes TD; McGonagle D; Mackie SL; Morgan AW; Cook G; Feyler S; Richards SJ; Davies FE; Morgan GJ; Cook GP
    Cancer Res; 2007 Sep; 67(18):8444-9. PubMed ID: 17875681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.
    Kopp HG; Placke T; Salih HR
    Cancer Res; 2009 Oct; 69(19):7775-83. PubMed ID: 19738039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.